Cargando…
Novel Prostate Cancer Biomarkers Derived from Autoantibody Signatures()
BACKGROUND: Due to the low specificity of the prostate-specific antigen (PSA) assay and a high false positive rate, a large number of prostate cancer (PCA) biopsies are performed unnecessarily. Consequently, there is a need for new biomarkers that can identify PCA at any stage of progression while l...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Neoplasia Press
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4415116/ https://www.ncbi.nlm.nih.gov/pubmed/25926076 http://dx.doi.org/10.1016/j.tranon.2015.02.003 |